To coincide with International Women’s Day on 8 March 2026, the National Rheumatoid Arthritis Society (NRAS) has launched a new Rheumatoid Arthritis & Menopause booklet. Developed in collaboration with the British Menopause Society medical advisory council and the rheumatology community, the booklet provides clear, evidence‑based guidance to help women understand how hormonal changes may [...]
The Royal College of Psychiatrists (RCPsych) has published its first Position Statement on menopause and mental health. Menopause can have a significant impact on women’s mental health and wellbeing. The RCPsych Position Statement sets out strategic aims, explains available evidence and gaps in knowledge, outlines the College’s position, and concludes by putting forward key [...]
Menopause is linked to reductions in grey matter volume in key brain regions as well as increased levels of anxiety and depression and difficulties with sleep, according to new research from the University of Cambridge. The study, published today in Psychological Medicine, found that hormone replacement therapy (HRT) does not appear to mitigate these effects, [...]
We are deeply saddened to learn of the untimely death of Gill Cheesbrough. Gill was a very supportive trustee of the British Menopause Society who provided sound financial advice over many years. A full obituary will be published in the March edition of the BMS journal.
Menopause will be among the priorities for the new NHS online hospital when it launches next year. The NHS has selected nine common conditions which will be the first to be treated by the NHS Online service, providing faster access to specialist care. Women’s health issues including severe menopause symptoms and menstrual problems that [...]
The Royal College of Nursing (RCN) has updated its guidance on the role of a Nurse Specialist in Menopause.This updated publication focuses on the professional development options available for nurses who wish to consider a career pathway that leads to becoming a specialist practitioner in menopause care. Further information is available on the RCN website: Nurse Specialist [...]
To add to the treatment options available for patients, a drosperinone containing oral hormone replacement therapy is now available in the UK. The product contains 1 mg estradiol and 2 mg drosperinone in a continuous combined regimen. This product may not yet be available on local formularies and it has not yet been added [...]
PhD studentship opportunity - improving equitable access to menopause care in Scotland Applications are now open for a funded PhD studentship opportunity at the University of Glasgow, focused on addressing inequities in menopause care in Scotland. The project will take a transdisciplinary approach, working with women from diverse communities, clinicians and policy actors to co-produce [...]
An updated BMS consensus statement is now available on the BMS website on the topic of Genitourinary Syndrome of Menopause (GSM).Genitourinary Syndrome of Menopause (GSM) is a chronic and progressive condition due to estrogen deficiency, most commonly associated with the menopause. There is a potential negative impact on all urogenital tissue quality including the vulva, [...]
A new two dose, twice weekly combined 17B oestradiol and norethisterone patch is now available to complement existing options for HRT prescribing. Licensed for postmenopausal women with estrogen deficiency symptoms, the new patch offers either 30 mcg 17B oestradiol with 95 mcg norethisterone or 40 mcg 17B oestradiol with 130 mcg norethisterone. Professor Janice [...]
